Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G P McCann

Showing results (11-20 of 27) with videos related to

Pageof 3
Sort By:
European Heart Journal. Cardiovascular Imaging|August 7, 2019
The utility of native T1 mapping in understanding dual and 'competing' pathologiesMatthew Paul Graham-Brown, G S Gulsin, G P McCann, et al.
International Journal of Cardiology|April 3, 1999
The ergoreflex in patients with chronic stable heart failureD A Grieve, A L Clark, G P McCann, et al.
Clinical Pharmacology and Therapeutics|August 3, 1999
Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonistD F Muir, G P McCann, L Swan, et al.
Heart (British Cardiac Society)|September 22, 1999
Responses to constant work exercise in patients with chronic heart failureN M Picozzi, A L Clark, K A Lindsay, et al.
British Journal of Clinical Pharmacology|April 6, 1999
The haemodynamic effect of the 5HT1 agonist BMS-180048: a class effect of triptans?L Swan, S Hood, D H Birnie, et al.
The British Journal of Radiology|March 30, 2012
Stress cardiovascular MR in routine clinical practice: referral patterns, accuracy, tolerance, safety and incidental findingsJ P Khoo, B J Grundy, C D Steadman, et al.
Clinical Science (London, England : 1979)|May 18, 2000
Sumatriptan reduces exercise capacity in healthy males: a peripheral effect of 5-hydroxytryptamine agonism?G P McCann, H Cahill, S Knipe, et al.
BMC Primary Care|October 16, 2025
Developing core indicators for identifying people at risk of delayed heart failure diagnosisK Barber, L Bernhardt, G P McCann, et al.
BMC Nephrology|July 13, 2019
Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathyM P Graham-Brown, A Singh, J Wormleighton, et al.
Cardiovascular Diabetology|July 22, 2016
Rationale and design of the randomised controlled trial to assess the impact of liraglutide on cardiac function and structure in young adults with type 2 diabetes (the LYDIA study)Z Z Htike, T Yates, E M Brady, et al.
Pageof 3

Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
European Heart Journal. Cardiovascular Imaging|August 7, 2019
The utility of native T1 mapping in understanding dual and 'competing' pathologiesMatthew Paul Graham-Brown, G S Gulsin, G P McCann, et al.
International Journal of Cardiology|April 3, 1999
The ergoreflex in patients with chronic stable heart failureD A Grieve, A L Clark, G P McCann, et al.
Clinical Pharmacology and Therapeutics|August 3, 1999
Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonistD F Muir, G P McCann, L Swan, et al.
Heart (British Cardiac Society)|September 22, 1999
Responses to constant work exercise in patients with chronic heart failureN M Picozzi, A L Clark, K A Lindsay, et al.
British Journal of Clinical Pharmacology|April 6, 1999
The haemodynamic effect of the 5HT1 agonist BMS-180048: a class effect of triptans?L Swan, S Hood, D H Birnie, et al.
The British Journal of Radiology|March 30, 2012
Stress cardiovascular MR in routine clinical practice: referral patterns, accuracy, tolerance, safety and incidental findingsJ P Khoo, B J Grundy, C D Steadman, et al.
Clinical Science (London, England : 1979)|May 18, 2000
Sumatriptan reduces exercise capacity in healthy males: a peripheral effect of 5-hydroxytryptamine agonism?G P McCann, H Cahill, S Knipe, et al.
BMC Primary Care|October 16, 2025
Developing core indicators for identifying people at risk of delayed heart failure diagnosisK Barber, L Bernhardt, G P McCann, et al.
BMC Nephrology|July 13, 2019
Association between native T1 mapping of the kidney and renal fibrosis in patients with IgA nephropathyM P Graham-Brown, A Singh, J Wormleighton, et al.
Cardiovascular Diabetology|July 22, 2016
Rationale and design of the randomised controlled trial to assess the impact of liraglutide on cardiac function and structure in young adults with type 2 diabetes (the LYDIA study)Z Z Htike, T Yates, E M Brady, et al.
Pageof 3